1Weinstein MH, Signoretti S, Loda M. Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells. Mod Pathol,2002,15(12):1302-1308.
2Signoretti S, Waltregny D, Dilks J, et al. p63 is a prostate basal cell marker and is required for prostate development. Am J Pathol,2000,157(6):1769-1775.
3Di Como CJ, Urist MJ, Babayan I,et al.p63 expression profiles in human normal and tumor tissues. Clin Cancer Res,2002,8(2):494-501.
4Wojno KJ, Epstein JI.The utility of basal cell-specific anti-cytokeratin antibody (34betaE12) in the diagnosis of prostate cancer. A review of 228 cases. Am J Surg Pathol,1995,19(3):251-260.
5Irwin Ms, Kaelin, WG Jr.Role of the p53 family proteins in malignancy. Apoptosis,2001,6(1-2):17-29.
6Shah RB, Zhou M, LeBlanc M,et al.Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer. Am J Surg Pathol,2002,26(9):1161-1168.
7Zhou M, Shah R, Shen R,et al.Basal cell cocktail (34betaE12+p63) improves the detection of prostate basal cells. Am J Surg Pathol,2003,27(3):365-371.
8Davis LD, Zhang W, Merseburger A, et al.p63 expression profile in normal and malignant prostate epitheial cells. Anticancer Res,2002,22(6c):3819-3825.
9Parsons JK, Gage WR, Nelson WG, et al.p63 protein expression is rare in prostate adenocarcinoma: implications for cancer diagnosis and carcinogenesis. Uroligy,2001,58(4):619-624.
